BACKGROUND: As benign prostatic hyperplasia (BPH) becomes increasingly prevalent, there is a growing need for simple and accurate methods to predict its risk. This study aimed to develop and validate a prediction model to identify males at high risk ...
OBJECTIVE: Artificial intelligence (AI) and its subsects, such as machine learning (ML) and virtual reality (VR) are subject to great interest from the urological community, and gaining space in the surgical treatment of benign prostatic hyperplasia ...
The rapid advancement of artificial intelligence, particularly large language models like ChatGPT-3.5, presents promising applications in healthcare. This study evaluates ChatGPT-3.5's validity in responding to post-operative patient inquiries follow...
Existing research indicates that bicalutamide and zoladex show significant potential in treating prostate cancer. However, in the clinical application of treating benign prostatic hyperplasia (BPH), it is limited due to relatively severe side effects...
Prostate cancer (PCa) diagnosis remains challenging due to overlapping clinical features with benign prostatic hyperplasia (BPH) and limitations of existing diagnostic tools like PSA tests, which yield high false-positive rates. This study investigat...
INTRODUCTION: Benign prostatic hyperplasia (BPH) affects a growing proportion of the aging male population. Minimally invasive surgical therapies (MISTs) such as Rezum and UroLift offer effective alternatives to traditional approaches like transureth...
INTRODUCTION: Transient stress urinary incontinence (SUI) after holmium laser enucleation of prostate (HoLEP) is commonly linked to intraoperative injury of the external urethral sphincter (EUS). We assessed the reliability of the post-HoLEP endoscop...
PURPOSE OF REVIEW: Benign prostatic hyperplasia (BPH) is prevalent in nearly 70% of men over the age of 60, leading to significant clinical challenges due to varying symptom presentations and treatment responses. The decision to undergo surgical inte...
Cardiovascular and interventional radiology
Jun 19, 2024
PURPOSE: This study leverages pre-procedural data and machine learning (ML) techniques to predict outcomes at one year following prostate artery embolization (PAE).
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.